Peptobiotics is a pioneering company in the agricultural sector, focusing on the development of innovative feed additives designed to enhance animal welfare, gut health, and growth. The company leverages advances in human medicine and synthetic biology to create a new class of feed additives that offer comparable performance to antibiotics but without the risk of creating drug-resistant superbugs. Peptobiotics serves livestock and aquaculture markets primarily in Asia, targeting farmers and agricultural businesses seeking sustainable and humane solutions for animal health.

The business model revolves around the production and sale of recombinant peptides, which are synthetic biology products manufactured through a patent-pending precision fermentation process. These peptides are customized for various livestock targets and applications, offering a cost-competitive alternative to traditional antibiotics and other high-cost pathogen defense systems like phages, antibody fragments, RNA, and probiotics.

Peptobiotics generates revenue by selling these innovative feed additives to agricultural businesses, aiming to make agriculture more productive, humane, and sustainable. The company's products not only inhibit harmful bacteria but also improve intestinal health and increase feed uptake efficiency, providing a holistic approach to animal health.

Keywords: feed additives, synthetic biology, animal welfare, gut health, livestock, aquaculture, antibiotic alternative, precision fermentation, pathogen defense, sustainable agriculture.